Adjuvant nivolumab after radical surgery can improve DFS and OS in patients with MIBC, results from the CheckMate 274 trial suggest.

Testosterone recovery was associated with improved OS in patients with high-risk prostate cancer treated with ADT and radiotherapy.

The FDA has approved Adcetris (brentuximab vedotin) for use in combination with lenalidomide and rituximab to treat patients with relapsed/refractory LBCL after 2 or more lines of systemic therapy who ...

Health Reform Will Provide Cancer Screening Services to Millions of Newly-Insured Women - but National Low-Income Screening Program Still 'Essential' ...

PORTOS can determine which patients with localized prostate cancer will benefit from dose-escalation of radiotherapy, data suggest.

Adding talazoparib to first-line treatment with enzalutamide can improve overall survival in patients with mCRPC, phase 3 data suggest.

The Trump Administration’s censorship extends beyond federal websites and datasets to include research to be published in academic journals.

Artificial intelligence systems require consistent monitoring and staffing to put in place and to keep them working well.

Patients with stage IA HER2+ breast cancer and smaller tumors had high BCSS rates whether they received adjuvant chemotherapy or not.

New research suggests that, from 2011 to 2023, there was an increase in early adult mortality in the United States.

Combination treatment with ibrilatazar and chemotherapy has demonstrated “promising efficacy and safety” in patients with advanced squamous non-small cell lung cancer (NSCLC), according to researchers ...

The NIH said capping indirect cost payments will save billions of dollars. Universities said it will disrupt vital, life-saving research.